TECX: Tectonic Therapeutic, Inc.
Performance
TECX +13.30%
Watchlist
Select an item
Summary
TECX at a glance
TECX returned +13.30% over the past year. Its worst drop in that year was -49.96%, smaller than 23% of stocks on Redstone, and its Sharpe ratio of 0.47 beats 49% of stocks on Redstone. It pays no dividends.
Current Drawdown
-42.29%
Rolling Volatility
58.11%
Actions
Metrics
Risk Indicators
Alpha23.64%
Beta1.04x
Sharpe0.47
Sortino0.76
Omega1.09
Calmar0.27
Martin1.62
Profile
About TECX
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $428M
- Listed
- Jun 2024
- Employees
- 60
- Headquarters
- Watertown, MA
- Website
- tectonictx.com
Comparisons